xRead - Swallowing Disorders in the Adult Patient (October 2024)

15314995, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/lary.31591, Wiley Online Library on [02/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

TABLE I. RCPD Questionnaire.

RCPD Questionnaire

1. I am unable to burp Never

Rarely

Occasionally

Frequently

Always

2. I experience abdominal bloating or abdominal discomfort, particularly associated with eating Never Rarely Occasionally

Frequently

Always

3. I experience chest pain or discomfort, particularly associated with eating Never Rarely 4. I experience gurgling or croaking noises from the chest, neck or throat Never Rarely

Occasionally

Frequently

Always

Occasionally

Frequently

Always

5. I am unable to vomit Never

Rarely

Occasionally

Frequently

Always

6. I modify my social interactions because of my symptoms Never Rarely

Occasionally

Frequently

Always

7. I am embarrassed by my symptoms Never Rarely 8. I modify my diet because of my symptoms Never Rarely

Occasionally

Frequently

Always

Occasionally

Frequently

Always

9. I have heartburn Never

Rarely

Occasionally

Frequently

Always

10. I experience regurgitation (vomiting into the throat) Never Rarely

Occasionally

Frequently

Always

11. At present I fi nd my symptoms to be Not a problem 1 2

3

4

5

6

7

8

9

10

Unbearable

11 questions to evaluate the major and minor symptoms of RCPD and effects on quality of life. The fi rst 10 questions are scored from 1 to 5 (1: never, 5: always). The 11th question is score on a 10-point Likert scale.

TABLE II. Demographics of Study Participants.

IOGroup

ORGroup

Total

( n = 60)

( n = 48)

( n = 108)

Gender Male

32 28

21 27

53 55

Female

Age (mean)

28.73

29.63

29.13

Race

White

26

26

52

Black or African American

0 3 3

1 1 2

1 4 5

Asian Other

Prefer to not disclose

28

18

46

Ethnicity Hispanic or Latino or Spanish Origin

2

2

4

Not Hispanic or Latino or Spanish Origin

28 30

32 14

60 44

Prefer to not disclose

between all timepoints of follow-up ( p < 0.0001), except between scores subsequent to week 2 follow-up ( p >0.05), controlling for procedure type. RCPD Questionnaire scores were not signi fi cantly different between the OR and IO injection groups across the model ( p = 0.4924).

surveys at 1, 2, and 3 weeks. 39 patients (OR:23, IO:16) completed the 3-month survey. Total RCPD Questionnaire scores at pre-op and follow-up time points are displayed in Figure 1. There are statistically signi fi cant decreases in RCPD scores

Laryngoscope 00: 2024

Doruk et al.: Botulinum Toxin Injection for RCPD 3